Browsing: Health

Researchers at Michigan State University have developed a temperature-responsive gel designed to help chemotherapy patients retain their hair during treatment. The gel, which functions similarly to shampoo in application, was tested in preclinical studies and significantly reduced hair loss by

A North Carolina-based pet food manufacturer has issued a voluntary recall of several raw dog and cat food products following the detection of Salmonella and Listeria monocytogenes, prompting a nationwide health alert for pet owners and retailers. The recall, announced

Novo Nordisk has announced a major pricing shift for its diabetes drug Ozempic, offering it directly to U.S. patients without insurance for $499 per month. The new out-of-pocket price cuts the drug’s list cost by more than 50 percent and

New clinical guidelines released today by the American Heart Association and the American College of Cardiology recommend initiating treatment for high blood pressure earlier and call for a complete halt to alcohol consumption to reduce cardiovascular and cognitive health risks.

U.S. scientists and biotech company AOA Dx have developed a new blood test that can detect early-stage ovarian cancer with high accuracy, offering a potential breakthrough in diagnosing one of the deadliest gynecologic cancers. The findings were presented at the

Health authorities in Florida are investigating a foodborne illness outbreak linked to raw milk from an unnamed farm that has resulted in 21 confirmed cases of infection. According to the Florida Department of Health, patients have contracted Campylobacter and Shiga

The U.S. Food and Drug Administration (FDA) has elevated the recall classification for 64,800 pounds of Bunge North America Inc.’s European Style Butter Blend to a Class II level, signaling a higher risk of potential health consequences. The recall, originally

A new study has identified a potential link between the artificial sweetener sucralose and reduced effectiveness of cancer immunotherapy treatments in patients with melanoma and non-small cell lung cancer. The research, conducted by the University of Pittsburgh in collaboration with

The U.S. Food and Drug Administration (FDA) is calling for tighter federal control over 7-hydroxymitragynine (7-OH), a potent psychoactive compound derived from the kratom plant, citing its high potential for abuse and opioid-like effects. The agency has formally recommended classifying

The European Medicines Agency (EMA) has issued a positive recommendation for the authorization of lenacapavir, a twice-yearly injectable medication for HIV prevention. Marketed in Europe under the name Yeytuo by Gilead Sciences, the drug is now positioned for formal approval